Alexion Pharma (ALXN) Tops Q3 EPS by 4c; Boosts, Narrows FY13 Outlook
Tweet Send to a Friend
Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) reported Q3 EPS of $0.83, $0.04 better than the analyst estimate of $0.79 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
